Cardiology

Cepmed: Survey shows that Canadian Physicians Support the Use of Genetic Testing to Personalise and Improve Treatment, Despite Barriers to Adoption

Published in Cancer Weekly, October 11th, 2011

2011 OCT 11 -- Personalised medicine, the tailoring of medical treatment and prevention to the characteristics of each patient, is currently driving a shift in medical practice. Increasingly, drug therapy can be optimized based on an individual's genetic profile by predicting drug response, drug tolerability or risk of side effects.

"Oncologists routinely use molecular testing to select treatment for patients with breast cancer. Increasingly, molecular tests are available for selecting the most appropriate treatment in other cancers such as non-small cell lung cancer and colorectal cancer."- Dr. Charles Butts - Cross Cancer Institute

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2011-10-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry